25 / 29
Page 100
conferenceseries
.com
Volume 8
Epidemiology: Open Access
ISSN: 2161-1165
Epidemiology 2018
September 17-19, 2018
September 17-19, 2018 | Rome, Italy
8
th
International Conference on
Epidemiology & Public Health
Severe acute respiratory infection following glucocorticosteriods treatment of uncomplicated
influenza-like illness from pH1N1 influenza infection
Fa Xian Zhan
and
Xuesen Xing
Hubei Provincial Center for Disease Control and Prevention, China
Background:
Current most studies on glucocorticosteriods treating influenza only estimated risk of critical illness or death,
which were easily confused by early and later glucocorticosteriods treatment. We used sARI as endpoint and investigated risk
for receiving glucocorticosteriods before sARI onset.
Methods:
sARI case was defined as ILI whit pH1N1 infection and respiratory distress. Control was pH1N1 case other than
sARI, randomly selected from community. We compared glucocorticosteriods and other medications used before sARI onset
by matched case control study that was adjusted for age group and underlying disease, and estimated time-dependent risk and
dose-response at different time periods in the course of sARI cases.
Results:
34% of sARI cases received glucocorticosteriods before sARI onset compared to 3.8% of controls during equivalent
days (ORM-H=17,95%CI=2.1-135).Receiving glucocorticosteriods before sARI onset increased risk of developing subsequent
critical illness or death (ORM-H=5.7,95%CI=1.6-20.2),and the ORM-H increased from 5.7 to 8.5 while continued receiving
them after sARI onset, only receiving glucocorticosteriods after sARI onset did not increase risk of severe illness (ORM-
H=1.1,95%CI=0.3-4.6).Each increase in glucocorticosteriods dose of 1 mg/kg/day before sARI onset, the pMEWS at the time
of sARI onset increased by 0.62(R2=0.87).
Conclusions:
Early glucocorticosteriods treatment increased risk of sARI and subsequent critical illness or death, only
receiving glucocorticosteriods after sARI onset did not increase risk of severe illness.
Epidemiology (Sunnyvale) 2018, Volume 8
DOI: 10.4172/2161-1165-C1-021